Dermatol Clin. Jul;11(3) Epidermolysis bullosa acquisita and bullous systemic lupus erythematosus. Diseases of autoimmunity to type VII collagen. Bullous Systemic Lupus Erythematosus (BSLE) is a rare manifestation of . (BP), inflammatory variant of epidermolysis bullosa acquisita (EBA), and linear IgA. However, unlike epidermolysis bullosa acquisita, bullous systemic lupus erythematosus tends to respond dramatically to treatment with.

Author: Kajizahn Faukinos
Country: Malta
Language: English (Spanish)
Genre: Technology
Published (Last): 28 June 2016
Pages: 74
PDF File Size: 7.82 Mb
ePub File Size: 14.37 Mb
ISBN: 878-5-24577-816-9
Downloads: 90213
Price: Free* [*Free Regsitration Required]
Uploader: Shakagal

Edgardo Jose Escorcia Charris. Biociencias13 1.

Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Male systemic lupus erythematosus in a latin-American inception cohort of patients. Systemic lupus erythematosus in a multiethnic US cohort. Clinical, features, course, and outcome in patients with lateonset disease. Systemic lupus erythematosus best pract res clin Rheumatol.

Lupus ampolloso: un verdadero reto diagnóstico y terapéutico | Biociencias

Understanding the epidemiology and progression of systemic lupus erythematosus. The geoepidemiology of systemic lupus erythematosus. Am J Clin Dermatol ; J Invest Dermatol ; Autoantibodies lupuz type VII collagen have heterogeneous subclass and light chain compositions and their complement-activating capacities do not correlate with the inflammatory clinical phenotype.


J Clin Immunol ; J Invest Dermatol bullsoo Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen. Yell JA, Wojnarowska F. Bullous skin disease in lupus erythematosus.

Bullous systemic lupus erythematosus. Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous bulloao antigen 1, laminin-5, laminin- 6,and type VII collagen. Systemic lupus erythematosus occurring in a patient with epidermolysis bullosa acquisita.

Bullous systemic lupus erythematosus with milia and calcinosis. Bullous disease in systemic lupus erythematosus. J Am Acad Dermatol.

Bullous eruption of systemic lupus erythematosus. Vesiculobullous systemic lupus erythematosus. A report of four cases. Facial bullous systemic lupus erythematosus. Int J Dermatol ; Bullous systemic lupus erythematosus with cutaneous mucinosis and leukocytoclastic vasculitis.

Bullous Systemic Lupus Erythematosus

J Am Acad Dermatol ; Diagnostic methods in autoimmune subepidermal bullous diseases. Estelle Bu,loso, MD et al. Lihua Duan et al. Treatment of Bullous Systemic Lupus Erythematosus. Journal of Immunology Research.


Lupus Eritematoso Sistémico Bulloso en una niña de 10 años de edad. Reporte de un caso

Clinical evidence and immunologic bullodo. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: Belimumab in systemic lupus erythematosus. BMJ – Rheumatic and musculoskeletal diseases. William Stohl et al. Susan Manzi et al. Effects of belimumab, a B lymphocyte stimulator-specific inhibitor, on disease activity across multiple organ domains in patients with systemic lupus erythematosus: Vibeke Strand et al.

Improvements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomized controlled BLISS trials. Ann Rheum Dis ; Derechos de autor Biociencias. Enero a marzoBiociencias: